Are you a robot? [www.bloomberg.com]
FDA panel backs J&J’s ketamine-like depression drug [www.fiercebiotech.com]
Johnson & Johnson's nasal spray for depression wins FDA panel backing [www.yahoo.com]
F.D.A. Panel Recommends New Depression Treatment [www.nytimes.com]
A Ketamine-Based Nasal Spray for Depression Could Soon be Approved by the FDA [gizmodo.com]
First Big #Depression Advance Since #Prozac Nears FDA Approval https://t.co/T5SrqWKzp0#esketamine #ketamine #MDD
— Robert West PhD (@westr) February 13, 2019
The first major depression drug since Prozac just moved a step closer to FDA approval today: https://t.co/Enihf49iED
— Drew Armstrong (@ArmstrongDrew) February 12, 2019
F.D.A. Panel Recommends New Depression Treatment #ketamine #esketamine https://t.co/qoiaHtmWCm
— Christine Ann Denny (@DrChristineAnnD) February 13, 2019
FDA Panel Recommends New Depression Treatment. The active ingredients of ketamine, a popular club drug, show promise in battling deep despair. https://t.co/iJxrJw46zw Amazing to think a nasal spray could accomplish in hours what used to require electroshock therapy. #Esketamine
— Sanho Tree (@SanhoTree) February 13, 2019
F.D.A. Panel Recommends New Depression Treatment https://t.co/kATvMXvP5F
— Peggy Lipton (@mspeggylipton) February 13, 2019
I was way ahead of the curve on this https://t.co/IZK7K70OmN
— Eli Bosnick (@elibosnick) February 13, 2019
A ketamine-based nasal spray for depression could soon be approved by the FDA https://t.co/U4L95f1yIT #himss19 pic.twitter.com/M47UUQ1r4o
— Evan Kirstel at #HIMSS19 (@evankirstel) February 13, 2019